Company Overview and News
Stop missing out on important events!
SEOUL, South Korea, Aug. 26, 2016 /PRNewswire/ -- K-ICT Born2Global Centre (Born2Global), a major Korean government agency under the Ministry of Science, ICT and Future Planning (MSIP), records about US$29,090,000 in Korean startup investment for first half of the year, up 171 percent compared to the same period last year.
Novartis (NYSE:NVS), a Swiss biopharma, invested $1 billion into an R&D center in Shanghai that will complement its other two major R&D hubs - one in its Basel home and the other in Cambridge, Massachusetts. Originally announced in 2009, the facility will house up to 1300 employees. In 2009, Novartis employed just 130 people in its China R&D operation. The new center will focus on treatments for diseases that are prevalent in China and Asia, such as gastric and liver cancer, HBV and hepatic fibrosis.
SHANGHAI, April 5, 2016 /PRNewswire/ -- In China, the ongoing predicament of unbalanced medical resources has prevented the public from receiving effective medical care.